While DNMT3A mutations have been reported in hematologic malignancies, recent studies have linked DNMT3A mutations to developmental growth disorders, such as Tatton-Brown-Rachman syndrome and microcephaly dwarfism. Here, DNMT3A is linked to hematologic disorder.